Fully remote intensive trauma-focused treatment for PTSD and Complex PTSD

Autor: H. Bongaerts, E. M. Voorendonk, A. Van Minnen, L. Rozendaal, B.S.D. Telkamp, A. de Jongh

Publikováno v: European Journal of Psychotraumatology, Vol 13, Iss 2 (2022)

Background: It is unknown whether remotely delivered intensive trauma-focused therapy not only is an effective treatment for PTSD, but also for Complex PTSD. Objective: Testing the hypothesis that a brief, fully remotely administered intensive trauma

Externí odkaz: https://doaj.org/article/b0b4b77eecca42a699248cafde5114bb

Effectiveness of an intensive treatment programme combining prolonged exposure and eye movement desensitization and reprocessing for severe post-traumatic stress disorder

Autor: C. Van Woudenberg, E. M. Voorendonk, H. Bongaerts, H. A. Zoet, M. Verhagen, C. W. Lee, A. van Minnen, A. De Jongh

Publikováno v: European Journal of Psychotraumatology, Vol 9, Iss 1 (2018)

Background: There is room for improvement regarding the treatment of severe post-traumatic stress disorder (PTSD). Intensifying treatment to increase patient retention is a promising development. Objective: The aim of this study was to determine the

Externí odkaz: https://doaj.org/article/0a7cd99a23c54c509d5e0978ff6574d1

Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition.

Autor: Gerald S M A Kerner, Michel J B Koole, Alphons H H Bongaerts, Jan Pruim, Harry J M Groen, CTMM Air Force Consortium

Publikováno v: PLoS ONE, Vol 11, Iss 5, p e0149955 (2016)

In ALK-positive advanced NSCLC, crizotinib has a high response rate and effectively increases quality of life and survival. CT measurement of the tumor may insufficiently reflect the actual tumor load changes during targeted therapy with crizotinib.

Externí odkaz: https://doaj.org/article/ca1d43ed077d4854a98bd865769a3b38

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies

Autor: Erik F. J. de Vries, Alphons H. H. Bongaerts, Andor W. J. M. Glaudemans, Elisabeth G.E. de Vries, Lemonitsa H. Mammatas, Michel van Kruchten, Geke A. P. Hospers, Otto S. Hoekstra, Epie Boven, Catharina W Menke-van der Houven van Oordt, Clasina M Venema, Ronald Boellaard, Giulia Apollonio, Carolina P. Schröder, Bert van der Vegt, Henk M.W. Verheul

Publikováno v: Venema, C M, Mammatas, L H, Schröder, C P, van Kruchten, M, Apollonio, G, Glaudemans, A W J M, Bongaerts, A H H, Hoekstra, O S, Verheul, H M W, Boven, E, van der Vegt, B, de Vries, E F, de Vries, E G E, Boellaard, R, Menke-van der Houven van Oordt, C W & Hospers, G A 2017, ' Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies ', Journal of Nuclear Medicine, vol. 58, no. 12, pp. 1906-1912 . https://doi.org/10.2967/jnumed.117.193649
Journal of Nuclear Medicine, 58(12), 1906-1912. Society of Nuclear Medicine Inc.
Journal of Nuclear Medicine, 58(12), 1906-1912. SOC NUCLEAR MEDICINE INC

In addition to the well-known estrogen receptor (ER) and human epidermal growth factor receptor 2, the androgen receptor (AR) is also a potential drug target in breast cancer treatment. Whole-body imaging can provide information across lesions within

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c9c78b716f27b2285970d30bad2e4d
https://doi.org/10.2967/jnumed.117.193649

Zr-89-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease

Autor: Alfons H. H. Bongaerts, Wim J. Sluiter, Elisabeth G.E. de Vries, Sophie J. van Asselt, Johan R. de Jong, Thera P. Links, Bernard A. Zonnenberg, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers, Sjoukje F. Oosting, Julia D.J. Steinberg, Annemiek M E Walenkamp, Eelco W. Hoving, Anouk N A van der Horst-Schrivers

Publikováno v: Journal of Nuclear Medicine, 57(8), 1244-1250. SOC NUCLEAR MEDICINE INC

Patients with von Hippel-Lindau disease (VHL) are at risk to develop multiple tumors. The growth of lesions is unpredictable, and regular surveillance is critical for early treatment to control local damage. Vascular endothelial growth factor A (VEGF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254af1c1812f9a6fb4a4bb1dd60667c5
https://doi.org/10.2967/jnumed.115.167643